Document is current
Any future updates will be listed below
-
Authors
Stewart, Carli M. https://orcid.org/0000-0002-2288-2230
Siegler, Elizabeth L.
Sakemura, R. Leo https://orcid.org/0000-0002-0293-5577
Cox, Michelle J. https://orcid.org/0000-0002-2984-0834
Huynh, Truc https://orcid.org/0009-0003-7521-4185
Kimball, Brooke https://orcid.org/0009-0009-3308-2704
Mai, Long
Can, Ismail https://orcid.org/0000-0003-0569-5326
Manriquez Roman, Claudia
Yun, Kun https://orcid.org/0009-0000-2782-8527
Sirpilla, Olivia https://orcid.org/0000-0002-0634-407X
Girsch, James H.
Ogbodo, Ekene
Mohammed Ismail, Wazim https://orcid.org/0000-0002-1782-7296
Gaspar-Maia, Alexandre https://orcid.org/0000-0001-8528-5575
Budka, Justin
Kim, Jenny
Scholler, Nathalie https://orcid.org/0000-0003-3743-7102
Mattie, Mike
Filosto, Simone
Kenderian, Saad S. https://orcid.org/0000-0003-2767-3830
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (K12CA090628, R37CA266344-01)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Defense (CA201127)
- License Information
-
More Information
Article History
Received: 14 July 2023
Accepted: 22 August 2024
First Online: 12 September 2024
Competing interests
: S.S.K. is an inventor on patents in the field of CAR immunotherapy that are licensed to Novartis (through an agreement between Mayo Clinic, University of Pennsylvania, and Novartis). R.L.S., M.J.C., and S.S.K. are inventors on patents in the field of CAR immunotherapy that are licensed to Humanigen (through Mayo Clinic). S.S.K. is an inventor on patents in the field of CAR immunotherapy that are licensed to Mettaforge (through Mayo Clinic). S.S.K. receives research funding from Kite, Gilead, Juno, BMS, Novartis, Humanigen, MorphoSys, Tolero, Sunesis/Viracta, LifEngine Animal Health Laboratories Inc, and Lentigen. S.S.K. has participated in advisory meetings with Kite/Gilead, Calibr, Luminary Therapeutics, Humanigen, Juno/BMS, Capstan Bio, and Novartis. SSK has served on the data safety and monitoring board with Humanigen. S.S.K. has severed a consultant for Torque, Calibr, Novartis, Capstan Bio, and Humanigen. J.B., J.K., M.M., N.S., and S.F. are employed by Gilead. C.M.S., M.M., S.F., and S.S.K. are inventors on intellectual property related to this work. All other authors do not have competing interests to disclose at this time.
